167 related articles for article (PubMed ID: 33909260)
1. Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial.
Ni L; Wen Z; Hu X; Tang W; Wang H; Zhou L; Wu L; Wang H; Xu C; Xu X; Xiao Z; Li Z; Li C; Liu Y; Duan J; Chen C; Li D; Zhang R; Li J; Yi Y; Huang W; Chen Y; Zhao J; Zuo J; Weng J; Jiang H; Wang DW
Front Med; 2021 Oct; 15(5):704-717. PubMed ID: 33909260
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [
